Intravenous Ferric Carboxymaltose Improves Response to Postoperative Anemia Following Total Knee Arthroplasty: A Prospective Randomized Controlled Trial in Asian Cohort

Background: Ferric carboxymaltose (FCM) is an intravenous (IV) high-dose iron that is effective in the treatment of iron deficiency anemia. This study was performed to determine whether postoperative FCM infusion is effective at improving hemoglobin (Hb) responders, Hb and iron profiles, and the pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Keun Young, Koh, In Jun, Kim, Man Soo, Kim, Chulkyu, In, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103711/
https://www.ncbi.nlm.nih.gov/pubmed/35566482
http://dx.doi.org/10.3390/jcm11092357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103711/
https://www.ncbi.nlm.nih.gov/pubmed/35566482
http://dx.doi.org/10.3390/jcm11092357

Ejemplares similares